These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11266711)

  • 1. Organ allograft recipients develop HLA class I-specific T suppressor cells.
    Bruzzone P; Renna Molajoni E; Cinti P; Evangelista B; Peritore D; Poli L; Pretagostini R; Berloco P; Cortesini R; Cortesini NS
    Transplant Proc; 2001; 33(1-2):78-9. PubMed ID: 11266711
    [No Abstract]   [Full Text] [Related]  

  • 2. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
    Minguela A; Sánchez-Bueno F; Marín L; Miras M; Pons JA; Muro M; Torío A; García-Alonso AM; Robles R; Parrilla P; Ramirez P; Alvarez-López MR
    Transplant Proc; 2001; 33(1-2):1384-5. PubMed ID: 11267338
    [No Abstract]   [Full Text] [Related]  

  • 3. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of dendritic cells with down-regulated CD80/CD86, but normal MHC class II expression after rat liver transplantation.
    Otto C; Ohrlein E; Meyer D; Timmermann W; Gassel HJ; Thiede A; Ulrichs K
    Transplant Proc; 2001; 33(1-2):442-4. PubMed ID: 11266901
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
    Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
    J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells.
    Cortesini R; Renna-Molajoni E; Cinti P; Pretagostini R; Ho E; Rossi P; Suciu-Foca Cortesini N
    Hum Immunol; 2002 Nov; 63(11):1010-8. PubMed ID: 12392853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.
    Naji A; Le Rond S; Durrbach A; Krawice-Radanne I; Creput C; Daouya M; Caumartin J; LeMaoult J; Carosella ED; Rouas-Freiss N
    Blood; 2007 Dec; 110(12):3936-48. PubMed ID: 17804694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of NF-kB activation in pig APC by xenospecific human T-suppressor cells.
    Ciubotariu R; Liu Z; Colovai AI; Li J; Cortesini R; Suciu Foca Cortesini N
    Transplant Proc; 2001; 33(1-2):708-9. PubMed ID: 11267030
    [No Abstract]   [Full Text] [Related]  

  • 10. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.
    Créput C; Durrbach A; Menier C; Guettier C; Samuel D; Dausset J; Charpentier B; Carosella ED; Rouas-Freiss N
    J Hepatol; 2003 Oct; 39(4):587-94. PubMed ID: 12971970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of T suppressor cells in patients with organ allografts.
    Ciubotariu R; Vasilescu R; Ho E; Cinti P; Cancedda C; Poli L; Late M; Liu Z; Berloco P; Cortesini R; Suciu-Foca Cortesini N
    Hum Immunol; 2001 Jan; 62(1):15-20. PubMed ID: 11165711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immune response to kidney allograft. Part I: the role of MHC antigens, antigen-presenting cells, and lymphocytes in alloantigen recognition; two-signal activation of T cells].
    Kusztal M; Jezior D; Weyde W; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2007; 61():13-20. PubMed ID: 17245313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble human leukocyte antigen-G in pediatric renal transplantation.
    Zarkhin V; Bezchinsky M; Li L; Sarwal MM
    Transplantation; 2011 Jul; 92(1):e1-2. PubMed ID: 21691191
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of mouse cardiac allografts by costimulation in trans.
    Mandelbrot DA; Kishimoto K; Auchincloss H; Sharpe AH; Sayegh MH
    J Immunol; 2001 Aug; 167(3):1174-8. PubMed ID: 11466331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
    Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
    J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the B7 costimulatory pathway in allograft rejection.
    Pearson TC; Alexander DZ; Corbascio M; Hendrix R; Ritchie SC; Linsley PS; Faherty D; Larsen CP
    Transplantation; 1997 May; 63(10):1463-9. PubMed ID: 9175811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-2+ low density APCS are as effective as B7-2- small resting B cells in inducing specific unresponsiveness to minor histocompatibility (miH) antigen(s) in vivo.
    Niimi M; Rawsthorne MA; Morris PJ; Wood KJ
    Adv Exp Med Biol; 1997; 417():265-8. PubMed ID: 9286371
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of inducible lymphocyte costimulatory molecules in human renal allograft.
    Biancone L; Segoloni G; Turello E; Donati D; Bussolati B; Piccoli G; Camussi G
    Nephrol Dial Transplant; 1998 Mar; 13(3):716-22. PubMed ID: 9550652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.